Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clinigen's Peter George joins Ergomed board

This article was originally published in Scrip

Executive Summary

Guilford, UK-based drug development services company Ergomed has named Peter George to its board as a non-executive director – effective from 21 May 2014. Mr George is currently CEO of global speciality pharma Clinigen. As well as providing clinical development services, Ergomed is building a portfolio of co-development partnerships with pharma and biotech companies which share the risks of drug development.

UsernamePublicRestriction

Register

SC025431

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel